The IMID Forum
The Immune-Mediated Inflammatory Disease Forum
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Episodes
Mentioned books
Dec 13, 2021 • 48min
Insights at ACR 2021: PROs and JAK Treatment
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 12, 2021 • 47min
Insights at ACR 2021: Clinical Outcomes in RA
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 11, 2021 • 30min
Insights at ACR 2021: JAKs in Spondyloarthritis
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 10, 2021 • 32min
Insights at ACR 2021: COVID-19 Vaccination and Rituximab
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 9, 2021 • 39min
Insights at ACR 2021: Impact of COVID-19 on Practice
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 7, 2021 • 40min
Insights at ACR 2021: COVID Vaccinations
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 6, 2021 • 24min
Author Interview: Professor Atul Deodhar
Professor Atul Deodhar, professor of medicine at Oregon Health & Science University.
Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Atul Deodhar discusses his review on JAK-STAT signalling in spondyloarthritis and what that means for the use of JAK inhibitors for SpA treatment.
Dec 6, 2021 • 8min
Discussing Rheumatology: Risk of HZ with UPA, and JAKs in SpA
Prof Iain McInnes reviews two papers this month, and discusses the increased risk of HZ infection with upadacitinib, as well as the role of the JAK-STAT pathway in SpA pathenogenesis. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.
Nov 18, 2021 • 29min
Author Interview: Professor Roy Fleischmann
Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center.
Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Roy Fleishmann discusses the effect of baricitinib on inhibiting radiographic progression of structural joint damage over 5 years in patients with active RA.
Nov 9, 2021 • 26min
ACR 2021: Day 4 Highlights
Grace Wright presents the Day 4 highlights of the key abstracts and posters presented at ACR 2021.
